First Manhattan’s AMAG Pharmaceuticals AMAG Stock Holding History

First Manhattan’s Portfolio AMAG Stock Details AMAG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-58,125	Closed	-$1.12M	–	1479
2014 Q1	$1.12M	Sell	58,125 -726,719	-93%	-$15.4M	0.01%	398
2013 Q4	$19.1M	Sell	784,844 -119,920	-13%	-$2.82M	0.13%	123
2013 Q3	$19.4M	Hold	904,764	–	–	0.14%	117
2013 Q2	$20.1M	Buy	+904,764	New	+$19.9M	0.14%	113

Other funds holding AMAG

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

First Manhattan's AMAG Position: Q2 2014 in Review

First Manhattan sold out of AMAG Pharmaceuticals (AMAG) in Q2 2014, closing a stake of 58,125 shares — an estimated $1.12M sold.

First Manhattan first reported a position in AMAG in Q2 2013 and held it in 4 quarters. The position peaked at $20.1M in Q2 2013. 100 funds tracked by Wall St. Rank hold AMAG as of Q2 2014.

First Manhattan reported no remaining AMAG Pharmaceuticals position as of Q2 2014 after selling out during the quarter.
First Manhattan sold 58,125 AMAG Pharmaceuticals shares in Q2 2014, an estimated $1.12M.
First Manhattan first reported a position in AMAG Pharmaceuticals in Q2 2013 and held it in 4 quarters.
First Manhattan's AMAG Pharmaceuticals position peaked at $20.1M in Q2 2013.
100 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q2 2014.

Based on First Manhattan's 13F filing for Q2 2014, filed 14 Aug 2014.